These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 10071274)
41. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine. Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428 [TBL] [Abstract][Full Text] [Related]
42. Treatment outcome and prognostic factors of medulloblastoma. Wang KC; Lee JI; Cho BK; Kim IH; Kim JY; Shin HY; Ahn HS; Han DH J Korean Med Sci; 1994 Feb; 9(1):64-73. PubMed ID: 8068221 [TBL] [Abstract][Full Text] [Related]
43. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study. Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079 [TBL] [Abstract][Full Text] [Related]
44. Long-term results of a prospective study on the treatment of medulloblastoma in adults. Brandes AA; Franceschi E; Tosoni A; Blatt V; Ermani M Cancer; 2007 Nov; 110(9):2035-41. PubMed ID: 17823910 [TBL] [Abstract][Full Text] [Related]
45. Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study. Le Teuff G; Castaneda-Heredia A; Dufour C; Jaspan T; Calmon R; Devos A; McHugh K; Leblond P; Frappaz D; Aerts I; Zwaan CM; Ducassou S; Chastagner P; Verschuur A; Corradini N; Casanova M; Rubie H; Riccardi R; Le Deley MC; Vassal G; Geoerger B; Pediatr Blood Cancer; 2020 Jan; 67(1):e28032. PubMed ID: 31595663 [TBL] [Abstract][Full Text] [Related]
46. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962 [TBL] [Abstract][Full Text] [Related]
47. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011 [TBL] [Abstract][Full Text] [Related]
48. High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). Tarbell NJ; Friedman H; Polkinghorn WR; Yock T; Zhou T; Chen Z; Burger P; Barnes P; Kun L J Clin Oncol; 2013 Aug; 31(23):2936-41. PubMed ID: 23857975 [TBL] [Abstract][Full Text] [Related]
49. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood]. Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018 [TBL] [Abstract][Full Text] [Related]
50. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857 [TBL] [Abstract][Full Text] [Related]
51. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688 [TBL] [Abstract][Full Text] [Related]
52. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial. Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D; Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598 [TBL] [Abstract][Full Text] [Related]
53. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy]. Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458 [TBL] [Abstract][Full Text] [Related]
54. Embryonal tumors in the adult population: implications in therapeutic planning. Boiardi A; Silvani A; Eoli M; Fariselli L; Zappacosta B; Salmaggi A Neurol Sci; 2000 Feb; 21(1):23-30. PubMed ID: 10938199 [TBL] [Abstract][Full Text] [Related]
55. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. Jakacki RI; Zeltzer PM; Boyett JM; Albright AL; Allen JC; Geyer JR; Rorke LB; Stanley P; Stevens KR; Wisoff J J Clin Oncol; 1995 Jun; 13(6):1377-83. PubMed ID: 7751882 [TBL] [Abstract][Full Text] [Related]
56. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease. Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122 [TBL] [Abstract][Full Text] [Related]
57. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP). Rivera-Luna R; López E; Rivera-Marquez H; Rivera-Ortegón F; Altamirano-Alvarez E; Mercado G; Covarrubias G; Rueda-Franco F; Marhx-Bracho A; Gutiérrez P Childs Nerv Syst; 2002 Feb; 18(1-2):38-42. PubMed ID: 11935242 [TBL] [Abstract][Full Text] [Related]
58. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673 [TBL] [Abstract][Full Text] [Related]
59. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters. von Bueren AO; Kortmann RD; von Hoff K; Friedrich C; Mynarek M; Müller K; Goschzik T; Zur Mühlen A; Gerber N; Warmuth-Metz M; Soerensen N; Deinlein F; Benesch M; Zwiener I; Kwiecien R; Faldum A; Bode U; Fleischhack G; Hovestadt V; Kool M; Jones D; Northcott P; Kuehl J; Pfister S; Pietsch T; Rutkowski S J Clin Oncol; 2016 Dec; 34(34):4151-4160. PubMed ID: 27863192 [TBL] [Abstract][Full Text] [Related]
60. Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: results of a Children's Cancer and Leukaemia Group study. Pizer B; Donachie PH; Robinson K; Taylor RE; Michalski A; Punt J; Ellison DW; Picton S Eur J Cancer; 2011 Jun; 47(9):1389-97. PubMed ID: 21474302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]